SEC Says FDA Chemist Made $3.6M In Insider Trading
The U.S. Securities and Exchange Commission accused a Food and Drug Administration chemist in Maryland federal court on Tuesday of using internal information about upcoming drug approval decisions to make trades...To view the full article, register now.
Already a subscriber? Click here to view full article